---
figid: PMC11212082__jcav15p4328g007
pmcid: PMC11212082
image_filename: jcav15p4328g007.jpg
figure_link: /pmc/articles/PMC11212082/figure/F7/
number: Figure 7
figure_title: ''
caption: Effect of AT-II combined with IFN-γ on the immune microenvironment in vivo.
  (A) Representative images and (B) statistical results of PD-L1, CD4, PD-1, and CD8
  expression in the tumour population of lung metastatic C57BL/6 mice are shown as
  indicated by flow cytometry. ▲P<0.05, ▲▲P<0.01, vs. model group. **P<0.01, vs. IFN-γ
  and AT-II groups.
article_title: Atractylenolide II combined with Interferon-γ synergistically ameliorates
  colorectal cancer progression in vivo and in vitro by blocking the NF-kB p65/PD-L1
  pathway.
citation: Yangsheng Wu, et al. J Cancer. 2024;15(13):4328-4344.
year: '2024'

doi: 10.7150/jca.96647
journal_title: Journal of Cancer
journal_nlm_ta: J Cancer
publisher_name: Ivyspring International Publisher

keywords:
- Colorectal cancer
- Atractylenolide II
- Interferon-γ
- PD-L1.

---
